N/A
Completed N=319
Outcomes From a Mobile Smoking Cessation Program During a Monitoring Period of 6 Months
Source: ClinicalTrials.gov NCT03295643 ↗Enrolled (actual)
319
Serious AEs
0.0%
Results posted
Nov 2022
Primary outcomePrimary: Number of Participants Who Completed the Explore Stage — 283 Participants
Summary
Prospective, open label, single center clinical study enrolling 260 subjects in a mobile smoking cessation program using a smartphone app and a handheld breath sensor with coaching support over a six month period.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Completed the Explore Stage |
283 | — |
| PRIMARY Number of Participants Who Completed the Build Stage |
183 | — |
| PRIMARY Number of Participants Who Completed the Mobilize Stage |
139 | — |
| PRIMARY Number of Participants Who Completed the Quit Stage |
131 | — |
| PRIMARY Number of Participants Who Completed the Secure Stage |
126 | — |
| SECONDARY Readiness to Quit and Goals Related to Smoking Behavior |
94; 176; 11; 157; 114; 10 | — |
| SECONDARY Average Percentage Change in Cigarettes Per Day (CPD) by the Pre-Quit Stage |
-44.5 | — |
| SECONDARY Weeks of Active Engagement |
12.4 | — |
| SECONDARY Number of Participants Who Completed the Program |
272 | — |
| SECONDARY Quit Attempts |
2.4 | — |
| SECONDARY Quit Rate 7-day Point Prevalence |
102 | — |
| SECONDARY Quit Rate 30-day Point Prevalence |
88 | — |
| SECONDARY Number of Participants Who Reported Pivot Increased Their Motivation to Stop Smoking |
233 | — |
| SECONDARY Confidence to Quit |
4.2; 5.9; 6.4; 7.4 | — |
| SECONDARY Difficulty Maintaining Quit |
3.1; 4.9; 5.7; 6.8 | — |
Eligibility Criteria
Inclusion Criteria
- 18-65 years of age
- English speaking
- Smokes daily
- Smokes 5 or more cigarettes per day
- Owns and uses a smartphone (iPhone 5 and above, operating system iOS 9.0 and above, or, Android 4.4 and above, operating system Android 4.4 and above)
- Employed at least 20 hours per week
- Lives in the USA
- Understands and willing to sign the Informed Consent Form
Data sourced from ClinicalTrials.gov (NCT03295643). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.